Enhanced Fitness of a Helicobacter pylori

Adhesins, Bacterial / genetics Animals Bacterial Adhesion / genetics Bacterial Outer Membrane Proteins / genetics Disease Models, Animal Helicobacter Infections / microbiology Helicobacter pylori / genetics Humans Male Mice Mice, Inbred C57BL Mutation / genetics
animal model bacterial outer membrane proteins competition fitness genetic barcoding population dynamics

Journal

Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127

Informations de publication

Date de publication:
16 09 2021
Historique:
pubmed: 27 7 2021
medline: 16 11 2021
entrez: 26 7 2021
Statut: ppublish

Résumé

Helicobacter pylori genomes encode over 60 predicted outer membrane proteins (OMPs). Several OMPs in the Hop family act as adhesins, but the functions of most Hop proteins are unknown. To identify

Identifiants

DOI: 10.1128/IAI.00725-20 PMID: 34310886 PMC: PMC8445181
pubmed: 34310886
doi: 10.1128/IAI.00725-20
pmc: PMC8445181
doi:

Substances chimiques

Adhesins, Bacterial 0
BabA protein, Helicobacter pylori 0
Bacterial Outer Membrane Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0072520

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK058404
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007281
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA116087
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118932
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI039657
Pays : United States
Organisme : BLRD VA
ID : I01 BX004447
Pays : United States

Références

J Exp Med. 2003 Apr 7;197(7):813-22
pubmed: 12668646
Gastroenterology. 2009 May;136(6):1863-73
pubmed: 19457415
Infect Immun. 2007 Feb;75(2):1005-16
pubmed: 17101654
Eur J Cancer. 2015 Dec;51(18):2820-32
pubmed: 26589974
Int J Med Microbiol. 2002 Sep;292(3-4):247-56
pubmed: 12398215
Nucleic Acids Res. 1999 Aug 15;27(16):3325-33
pubmed: 10454640
mBio. 2020 May 19;11(3):
pubmed: 32430470
J Biol Chem. 2011 Jul 15;286(28):25256-64
pubmed: 21596743
Infect Immun. 1996 Jul;64(7):2445-8
pubmed: 8698465
Gastroenterology. 2017 Aug;153(2):420-429
pubmed: 28456631
N Engl J Med. 2002 Oct 10;347(15):1175-86
pubmed: 12374879
Nat Microbiol. 2016 Nov 07;2:16243
pubmed: 27819267
Nature. 2010 Mar 11;464(7286):250-5
pubmed: 20164839
FEMS Microbiol Rev. 2021 Jan 8;45(1):
pubmed: 32880636
Helicobacter. 2012 Apr;17(2):133-9
pubmed: 22404444
Infect Immun. 1994 Aug;62(8):3586-9
pubmed: 8039935
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2106-11
pubmed: 14762173
Gastroenterology. 1999 Jan;116(1):90-6
pubmed: 9869606
mBio. 2020 Aug 25;11(4):
pubmed: 32843556
mBio. 2020 Jun 30;11(3):
pubmed: 32605987
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8354-9
pubmed: 12060779
Infect Immun. 2000 Jul;68(7):4155-68
pubmed: 10858232
mBio. 2016 Jan 26;7(1):e01869-15
pubmed: 26814181
PLoS Pathog. 2011 May;7(5):e1002050
pubmed: 21589900
Bioinformatics. 2014 Jul 15;30(14):2070-2
pubmed: 24642064
J Clin Microbiol. 1994 Mar;32(3):790-2
pubmed: 8195395
Cell Host Microbe. 2017 Mar 8;21(3):376-389
pubmed: 28279347
Science. 1998 Jan 16;279(5349):373-7
pubmed: 9430586
Nature. 1997 Aug 7;388(6642):539-47
pubmed: 9252185
Mol Microbiol. 1999 Mar;31(5):1537-48
pubmed: 10200971
Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1515-9
pubmed: 7878011
Mol Microbiol. 1998 Apr;28(2):383-93
pubmed: 9622362
Mol Microbiol. 2018 Oct;110(1):33-46
pubmed: 29995350
Infect Immun. 2006 May;74(5):3046-51
pubmed: 16622249
J Infect Dis. 2011 Mar 1;203(5):726-35
pubmed: 21227917
Curr Protoc Mol Biol. 2001 Nov;Chapter 2:Unit 2.4
pubmed: 18265184
Nat Microbiol. 2016 Oct 17;2:16188
pubmed: 27748756
Infect Immun. 2011 Aug;79(8):3106-16
pubmed: 21576328
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1133-1138
pubmed: 28341758
Helicobacter. 2020 Oct;25(5):e12724
pubmed: 32677105
J Infect Dis. 2014 Oct 15;210(8):1286-95
pubmed: 24755437
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5024-9
pubmed: 15044704
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12778-83
pubmed: 10535999
Int J Cancer. 2015 Jan 15;136(2):487-90
pubmed: 24889903
Nat Commun. 2014 Jun 13;5:4165
pubmed: 24924186
Cancer Causes Control. 2013 Feb;24(2):217-31
pubmed: 23224270
PLoS Biol. 2019 May 2;17(5):e3000231
pubmed: 31048876
J Infect Dis. 2006 Nov 15;194(10):1346-55
pubmed: 17054063
Gut. 2000 May;46(5):601-7
pubmed: 10764701
PLoS Pathog. 2009 May;5(5):e1000407
pubmed: 19412339
Infect Immun. 2010 Apr;78(4):1593-600
pubmed: 20123715
Infect Immun. 1994 Sep;62(9):3604-7
pubmed: 8063376
mBio. 2016 Oct 11;7(5):
pubmed: 27729513
Science. 2002 Jul 26;297(5581):573-8
pubmed: 12142529

Auteurs

M Lorena Harvey (ML)

Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.

Aung Soe Lin (AS)

Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.

Lili Sun (L)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Tatsuki Koyama (T)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Jennifer H B Shuman (JHB)

Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.

John T Loh (JT)

Department of Medicine, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.

Holly M Scott Algood (HMS)

Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.
Department of Medicine, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.
Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee, USA.

Matthew B Scholz (MB)

Vanderbilt Technologies for Advanced Genetics (VANTAGE), Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.

Mark S McClain (MS)

Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.
Department of Medicine, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.
ORCID: 0000-0002-9857-4883

Timothy L Cover (TL)

Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.
Department of Medicine, Vanderbilt University School of Medicinegrid.471397.f, Nashville, Tennessee, USA.
Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee, USA.
ORCID: 0000-0001-8503-002X

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes bactériens › Adhésines bactériennes › Enhanced Fitness of a Helicobacter pylori
questionsmedicales.fr › Eucaryotes › Animaux › Enhanced Fitness of a Helicobacter pylori
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques bactériens › Adhérence bactérienne › Enhanced Fitness of a Helicobacter pylori
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Protéines de la membrane externe bactérienne › Enhanced Fitness of a Helicobacter pylori
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › Enhanced Fitness of a Helicobacter pylori
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Helicobacter › Enhanced Fitness of a Helicobacter pylori
questionsmedicales.fr › Bactéries › Proteobacteria › Epsilonproteobacteria › Campylobacterales › Helicobacteraceae › Helicobacter › Helicobacter pylori › Enhanced Fitness of a Helicobacter pylori
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Enhanced Fitness of a Helicobacter pylori
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Enhanced Fitness of a Helicobacter pylori
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée C57BL › Enhanced Fitness of a Helicobacter pylori
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Enhanced Fitness of a Helicobacter pylori